Performance on Wider system susceptibility testing with routine NFGNRsa
Antimicrobial agentb | % MICs obtained with Wider system within indicated log2 reference MICs: | % Essential agreement | % Errors | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
>−2 | −2 | −1 | 0 | +1 | +2 | >+2 | mi | M | VM | ||
Piperacillin (25) | 8.0 | 4.0 | 8.0 | 72.0 | 0.0 | 8.0 | 0.0 | 80.0 | 4.0 | 0.0 | 50.0 |
Piperacillin-tazobactam (25) | 4.0 | 0.0 | 4.0 | 72.0 | 12.0 | 4.0 | 4.0 | 88.0 | 4.0 | 7.7 | 4.0 |
Ceftazidime (25) | 0.0 | 8.0 | 4.0 | 72.0 | 12.0 | 4.0 | 0.0 | 88.0 | 4.0 | 5.2 | 0.0 |
Aztreonam (25) | 8.0 | 0.0 | 20.0 | 68.0 | 4.0 | 0.0 | 0.0 | 92.0 | 4.0 | 0.0 | 12.5 |
Cefepime (25) | 0.0 | 8.0 | 12.0 | 56.0 | 12.0 | 8.0 | 4.0 | 80.0 | 4.0 | 0.0 | 0.0 |
Imipenem (25) | 0.0 | 0.0 | 0.0 | 76.0 | 12.0 | 4.0 | 8.0 | 88.0 | 4.0 | 0.0 | 0.0 |
Meropenem (25) | 0.0 | 4.0 | 12.0 | 76.0 | 4.0 | 4.0 | 0.0 | 92.0 | 0.0 | 0.0 | 0.0 |
Gentamicin (25) | 0.0 | 0.0 | 0.0 | 80.0 | 8.0 | 8.0 | 4.0 | 88.0 | 8.0 | 0.0 | 0.0 |
Tobramycin (25) | 0.0 | 0.0 | 0.0 | 88.0 | 4.0 | 8.0 | 0.0 | 92.0 | 0.0 | 5.0 | 0.0 |
Amikacin (25) | 0.0 | 0.0 | 0.0 | 80.0 | 12.0 | 8.0 | 0.0 | 92.0 | NA | NA | NA |
Ciprofloxacin (25) | 0.0 | 4.0 | 4.0 | 84.0 | 0.0 | 8.0 | 0.0 | 88.0 | 0.0 | 0.0 | 16.6 |
Co-trimoxazole (25) | 0.0 | 8.0 | 12.0 | 64.0 | 12.0 | 4.0 | 0.0 | 88.0 | 0.0 | 4.0 | 8.0 |
Total (300) | 1.7 | 3.0 | 6.3 | 73.6 | 8.0 | 5.7 | 1.7 | 88.0 | 2.9 | 2.2 | 12.1 |